Global Swine Pneumonia Market, By Diagnosis (Serologic Tests, Polymerase Chain Reaction (PCR) Test, Others), Treatment (Vaccination, Antibiotics, Antibacterial, Others), Mode of Consultation (Over-the-Counter (OTC), Prescription), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others) – Industry Trends and Forecast to 2030.
Swine Pneumonia Market Analysis and Size
The initiation of swine influenza is generally sudden and affects the majority of pigs. Pneumonia is very common in pigs, and the incidence may range between 19% to 79%. It has been witnessed that injectable antibacterials are the best treatment for swine pneumonia signs. The right diagnosis of the numerous causes of pneumonia is essential for treating individual animals properly and managing, managing, and preventing pneumonia in swine herds.
Data Bridge Market Research analyses that the swine pneumonia market, which was USD 523.06 million in 2022, would rise to USD 859.18 million by 2030 and is expected to undergo a CAGR of 6.40% during the forecast period from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Swine Pneumonia Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnosis (Serologic Tests, Polymerase Chain Reaction (PCR) Test, Others), Treatment (Vaccination, Antibiotics, Antibacterial, Others), Market Type (Over-the-Counter (OTC), Prescription), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Mallinckrodt (U.S.), Elanco (U.S.), Boehringer Ingelheim International GmbH. (Germany), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Lilly (U.S.), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Cipla Inc. (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India)
|
|
Market Opportunities
|
|
Market Definition
Swine pneumonia is a disorder of the lower respiratory tract which affects the health of pigs. This illness can lead to lung inflammation, bacterial infection, and huge mortality in pigs, as well as a financial burden on the swine industry. Pneumonia in pigs is typically characterized by coughing and thumping. According to numerous studies, swine respiratory disorders are a combination of several infectious diseases and one of the leading causes of death in nursery pigs.
Global Swine Pneumonia Market Dynamics
Drivers
- Increasing Prevalence of Swine Pneumonia
There has been an increasing incidence of swine pneumonia that is escalating the market growth. Pneumonic processes were witnessed in 73.1% of the animals. They mostly consisted of cranioventral bronchopneumonia (CBP) (46.3%) and pleuritis (17.6%). Also, bronchointerstitial pneumonia (67.4%) was prevalent and was occasionally combined (27.9%) with interstitial pneumonia (IP). It has been seen that pneumonia is common in pigs, and the incidence varies between 19% to 79%, based on region, production system, or lung lesion scoring system used. This increasing prevalence resulted in higher treatment processes for this disease. Thus, this factor leads to the growth of the market.
- Varied Diagnostic Methods for Swine Pneumonia
Various signs of diagnostic methods are used for the early treatment processes of pneumonia. The typical clinical signs involve coughing, rapid breathing, a high temperature, and post-mortem examinations. Other methods, such as laboratory tests that involves serology and microbiology, are essential to identify the possible causes. Thus, all these tests are important for the diagnostics of this disease.
Opportunities
- Increasing Availability of Varied Treatment Processes
Usually, pneumonia in pigs involves a combined infection of viruses and secondary bacteria. With regard to its treatment, broad-spectrum antibiotics such as OTC, penicillin-streptomycin, or amoxicillin are recommended. The injection is also suitable and should be applied daily for 3 to 4 days. Sometimes, CTC or OTC in the water and in-feed medication at 600g/tonne are also preferred. Antibiotic coverage is essential for at least 14 to 21 days. Numerous medications are available for the treatment, such as spectinomycin, lincomycin, tiamulin, chlortetracycline, tylosin, and oxytetracycline. Thus, this factor boosts market growth.
- Increasing Vaccine Approvals and Research for Swine Pneumonia
There are varied research activities carried out concerning vaccine production that boosts market growth. For instance, the RespiSure vaccine is approved for healthy swine vaccination to help prevent chronic pneumonia caused by Mycoplasma hyopneumoniae. It can be administered as early as one week of age with a booster shot two weeks later. This vaccine is suitable for pregnant swine, which may be safely vaccinated 6 and 2 weeks after farrowing. Thus, this factor escalates the market growth.
Restraints/Challenges
- Lack of Skilled Veterinarians
A lack of professional and skilled veterinarians who can handle pneumonia in pigs can lead to market obstruction. This very sensitive disease can affect majorly if not treated properly. Not all professionals can handle the pigs with the utmost knowledgeable treatment methods. Thus, this factor impedes market growth.
This swine pneumonia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the swine pneumonia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Swine Pneumonia Market Scope
The swine pneumonia market is segmented on the basis of diagnosis, treatment, mode of consultation, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
- Serologic Tests
- Polymerase Chain Reaction (PCR) Test
- Others
Treatment
- Vaccination
- Antibiotics
- Antibacterial
- Others
Mode of Consultation
- Over-the-Counter (OTC)
- Prescription
End Use
- Veterinary Hospitals
- Veterinary Specialty Clinics
- Others
Distribution Channel
- Veterinary Hospital Pharmacy
- Retail Pharmacy
- Veterinary Research Institute
- Others
Swine Pneumonia Market Regional Analysis/Insights
The swine pneumonia market is analyzed and market size insights and trends are provided by diagnosis, treatment, mode of consultation, end user and distribution channel as referenced above.
The countries covered in the swine pneumonia market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to grow during the forecast period of the swine pneumonia market because of the increasing occurrence of swine pneumonia, which further lead to the increased vaccination demand in this region. Furthermore, the high development of healthcare infrastructure will further boost this region's market's growth rate.
North America dominates the market in the forecast period because of the increasing awareness about vaccination among animal owners and increasing healthcare expenditure in this region. Furthermore, the presence of major market players will further boost the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The swine pneumonia market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for swine pneumonia market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the swine pneumonia market. The data is available for historic period 2011-2021.
Competitive Landscape and Swine Pneumonia Market Share Analysis
The swine pneumonia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to swine pneumonia market.
Some of the major players operating in the swine pneumonia market are:
- Sanofi (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mallinckrodt (U.S.)
- Elanco (U.S.)
- Boehringer Ingelheim International GmbH. (Germany)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Lilly (U.S.)
- Merck & Co., Inc. (U.S.)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Cipla Inc. (U.S.)
- Abbott (U.S.)
- AbbVie Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
SKU-